2-(2,6-dimethyl-4-pyridinyl)-5-[1-[(2-methylpyrazol-3-yl)methyl]piperidin-4-yl]-3-propan-2-yl-1H-indole
C28H35N5 — CID 134329722
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(2,6-dimethyl-4-pyridinyl)-5-[1-[(2-methylpyrazol-3-yl)methyl]piperidin-4-yl]-3-propan-2-yl-1H-indole
2-(2,6-dimethyl-4-pyridinyl)-5-[1-[(2-methylpyrazol-3-yl)methyl]piperidin-4-yl]-3-propan-2-yl-1H-indole (PubChem CID 134329722) has the molecular formula C28H35N5 and a molecular weight of 441.62 g/mol. Its IUPAC name is 2-(2,6-dimethyl-4-pyridinyl)-5-[1-[(2-methylpyrazol-3-yl)methyl]piperidin-4-yl]-3-propan-2-yl-1H-indole.
Molecular Properties
| Compound Name | 2-(2,6-dimethyl-4-pyridinyl)-5-[1-[(2-methylpyrazol-3-yl)methyl]piperidin-4-yl]-3-propan-2-yl-1H-indole |
|---|---|
| PubChem CID | 134329722 |
| Molecular Formula | C28H35N5 |
| Molecular Weight | 441.62 g/mol |
| Exact Mass | 441.29 |
| IUPAC Name | 2-(2,6-dimethyl-4-pyridinyl)-5-[1-[(2-methylpyrazol-3-yl)methyl]piperidin-4-yl]-3-propan-2-yl-1H-indole |
| SMILES | Cc1cc(-c2[nH]c3ccc(C4CCN(Cc5ccnn5C)CC4)cc3c2C(C)C)cc(C)n1 |
| InChI | InChI=1S/C28H35N5/c1-18(2)27-25-16-22(21-9-12-33(13-10-21)17-24-8-11-29-32(24)5)6-7-26(25)31-28(27)23-14-19(3)30-20(4)15-23/h6-8,11,14-16,18,21,31H,9-10,12-13,17H2,1-5H3 |
| InChIKey | YAQGQSZTCUPAKS-UHFFFAOYSA-N |
| XLogP | 6.08 |
| TPSA | 49.74 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 441.62 |
| LogP ≤ 5 | 6.08 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134329722 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.